| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,564 |
14,523 |
$1.03M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,259 |
17,630 |
$1.00M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
10,374 |
10,114 |
$648K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,498 |
7,328 |
$648K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,426 |
6,185 |
$193K |
| 99058 |
|
1,234 |
1,118 |
$78K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,662 |
1,893 |
$47K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,512 |
1,254 |
$43K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,181 |
3,990 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,274 |
2,203 |
$27K |
| 99000 |
|
12,446 |
11,117 |
$26K |
| 87428 |
|
1,123 |
1,027 |
$21K |
| 81025 |
|
1,767 |
1,719 |
$11K |
| 81002 |
|
4,557 |
4,429 |
$11K |
| 87210 |
|
1,977 |
1,925 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
181 |
175 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
1,888 |
1,853 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
67 |
67 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
628 |
601 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
339 |
330 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,923 |
1,848 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
77 |
77 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,162 |
1,146 |
$878.32 |
| 69210 |
|
12 |
12 |
$238.95 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
67 |
67 |
$217.83 |
| 87807 |
|
17 |
17 |
$119.35 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
24 |
24 |
$22.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
26 |
$5.11 |
| 99051 |
|
872 |
839 |
$5.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15 |
14 |
$2.64 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
25 |
24 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
17 |
15 |
$0.00 |